CartilaGen

CartilaGen

Developing drug-eluting bioactive materials to treat articular cartilage damage and osteoarthritis.
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$25.0k

Grant

N/A

Grant
*
N/A

N/A

Grant
*

$125k

Grant
Total Funding€136k

Recent News about CartilaGen

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.